Squamous cell papilloma larynx

Virusul Papiloma - potenţială cauză în cazul neoplasmelor orofaringian și laringian

In addition to tobacco and alcohol abuse, certain viruses have been associated with squamous cell carcinoma SCC of the head and neck, causing alterations in DNA.

Ричард пожал плечами. - На Раме мы вели себя ничуть не хуже, чем многие столетия на Земле. Кстати, едва ли далеко опередившие нас инопланетные существа способны делать столь субъективные суждения.

Если они наблюдают за космоплавателями десятки тысячелетий, как утверждал Орел, значит, у раман давно выработана количественная методика. Безусловно, их скорее интересует наша суть - все, что можно подразумевать под этим словом, - чем хороши мы или плохи.

It has been demonstrated that the human papil­loma­virus HPV type 16, a subtype of the human pa­pil­loma­virus, is present in the oropharyngeal carcinomas of non-smokers patients inclusive. HPV-infected cells express some viral proteins encoded by warts treatment malaysia called E6 and E7, and can inactivate p53 protein and the retinoblastoma-type pro­tein RBP involved in the regulation of proliferation and cell death.

Materials and method. We present an immunohistochemical study conducted to identify significant tumour markers in tonsillar SCC. We present the sta­tis­tically significant correlations between the presence of immunohistochemical markers and studied local re­cur­rence, lymph node recurrence and risk of a second can­cer in the aerodigestive upper tract.

The de­mon­stration of HPV in tonsillar tumour tissue requires in situ hybridization or polymerase chain reaction PCR for the evidence of viral genome included into the host cell. The practical implications of an etiologic role of HPV in head and neck cancer generally and in tonsillar SCC in particular remains in question and is in relate with prog­nosis, treatment and prevention.

În afară de consumul de tutun şi abuzul de al­cool, anumite virusuri au fost asociate squamous cell papilloma larynx carcinomul cu celule scuamoase CCS al capului şi gâtului, cauzând al­te­rări la nivelul ADN-ului.

Este dovedit că virusul papiloma uman HPVtipul 16, este prezent la nivelul carcinoamelor orofaringiene inclusiv în cazul nefumătorilor. Celulele in­fec­ta­te cu HPV exprimă unele proteine virale codate de ge­ne­le denumite E6 şi E7 şi pot inactiva proteina p53 şi pro­tei­na de tip retinoblastom RBP implicate în reglarea pro­li­fe­ră­rii şi morţii celulare.

Materiale şi metodă. Pre­zen­tăm un stu­diu imunohistochimic realizat cu scopul de a identifica mar­keri tumorali semnificativi în CCS de amig­da­lă. Pre­zen­tăm co­re­la­ţiile semnificative statistic între prezenţa mar­ke­rilor imu­no­his­to­chimici şi recurenţa locală, recurenţa no­du­lilor limfatici şi ris­cul apariţiei unui al doilea cancer în squamous cell papilloma larynx aerodigestiv su­pe­rior.

Punerea în evidenţă wart and foot pain HPV-ului în ţesutul tu­mo­ral amigdalian necesită hibridizare in situ şi reacţie de polimerizare în lanţ PCR pentru punerea în evidenţă a genomului viral conţinut în celula-gazdă.

Im­pli­caţiile practice ale unui rol etiologic al HPV-ului în can­ce­rele de cap şi gât, în general, şi în CCS de amigdală, în par­ti­cu­lar, reprezintă un subiect în dezbatere, fiind în relaţie cu prog­nos­ticul, tratamentul şi prevenţia acestor tipuri de can­cere. Cuvinte cheie carcinomul cu celule scuamoase de amigdală CCS HPV markeri tumorali Introduction The tonsillar squamous squamous cell papilloma larynx carcinoma SCC is becoming a public health problem because of its rising incidence in the last 20 years, in contrast to the decreasing incidence of carcinomas in other subsites of head and neck squamous cell papilloma larynx to the reduced prevalence of smoking.

These tumours of oral cavity, oropha­rynx, larynx, hypopharynx and sinonasal region are linked by common characteristics, including a male predominant appearance in the squamous cell papilloma larynx decade of life, an important etiological link with tobacco, alcohol use or betel nut chewing, and a histopathological resemblance 1.

Data regarding the epidemiology revealed that in Romania the oropharyngeal cancer represents 2. In France, during the last 30 years, the mortality in oral and oropharyngeal cancer increased by three times 1. As in cervical cancers, the oropharyngeal infection with HPV is a sexually transmitted disease which involves some particularities of sexual behaviour: a large number of vaginal sex partners, oral and anal sex. The recent increasing of OPSCC incidence may reflect the social changes regarding sexual behaviour in the modern world 6.

The anatomical sites preferred by HPV in oropharynx are the tonsils and the tongue, because of the unique presence of transitional mucosa in oropharynx and particular in tonsillar tissue, which presents important histological similarities with the cervical mucosa.

Tonsillar epithelium invagination may favour virus capture and promote its access to basal cells the only dividing cells in the epithelium.

The tonsillar tissue could be a reservoir for HPV in the upper aero digestive tract.

Ale mucoaselor genitale; oro-faringo-laringiene. Infecțiile asimptomatice sunt evidențiate cu ajutorul testelor HPV-ADN, din probe prelevate de la nivelul epidermei sau al mucoaselor, ce nu prezintă modificări din punctul de vedere al structurii țesutului 3. Cât le privește pe cele simptomatice productivedin care fac parte verucile, acestea sunt puse în evidență la o simplă examinare clinică 3.

We had two premises for our study on tonsillar cancers. The second consists in the fact that mutagens such as tobacco, alcohol and HPV viral oncogenes E6 and E7 urticarie de la oxiuri dysfunctions of two major mechanisms of cellular cycle, which involves the p53 and RBP tumoral suppressor genes 2. Materials and method We made an immunohistochemical retrospective study between andaiming to identify any correlations between tumoral markers and the evolution and prognosis in tonsillar SCC.

Materials We studied 52 cases of patients diagnosed with tonsillar SCC. We had a first group Group Squamous cell papilloma larynx with 25 cases, where the positive diagnose was made by biopsy and these patients had radiotherapy as first curative method of treatment. We had a second group Group II with 27 cases, where the positive diagnose squamous cell papilloma larynx made on surgical specimens and these patients had surgery as the first curative method of treatment.

The two groups were similar regarding age and gender distribution. The dilutions and human papillomavirus infection specifications are revealed in Table 1. We also studied lymphocyte populations CD4, CD8, and populations of dendritic cells in tumour tissue. Table 1. The dilutions and markers specifications For the immunohistochemical identification of tumoral antigens we used the three-stadial indirect method Avidine-Biotine-Peroxidase ABPafter Hsu and colab.

Results The gender repartition of cases was: 47 male cases and 5 female cases. The age repartition of cases was: two cases between years old, 14 cases between years old, 21 cases between years old, 10 cases between years old, and five cases between years old.

The correlation coefficient between the two sets of data, corresponding to Group I and Group II, was 0. In both groups, we had 48 smoker patients, representing The patients who were both smokers and alcohol consumers represented We studied the tumoral markers on 52 cases of squamous cell carcinoma.

Thirty-eight cases were well differentiated carcinoma and 14 cases were medium differentiated carcinoma. We present the results, that we considered immunohistochemically valid and statistically significant Table 2. Table 2.

squamous cell papilloma larynx

The distribution of tumoral markers in specimens of SCC studied Squamous cell papilloma larynx realised a correlation between the presence squamous cell papilloma larynx the tumoral marker of a certain type positive and slowly positive results and the post-therapeutic evolution — local recurrence, nodal relapse, the occurrence of second cancers in upper aerodigestive upper ways and distance metastases.

We have had patients who had more than squamous cell papilloma larynx recurrence in the same time. Our purpose was to identify the correlations between markers of evolution and prognosis in tonsillar SCC. Our results indicate p53 protein and RBP protein as tumoral markers of unfavourable prognosis for post-therapeutic evolution in tonsillar SCC.

For TGFa, we can make a correlation between its level in tumoral tissue and the risk of loco-regional relapse. For the HPV identification in tumoral tissue, we used the identification of capsid p16 protein, so we cannot make definitive conclusions referring at the presence or absence of HPV in the tumoral tissue for patients with tonsillar SCC.

Încărcat de

But we realised a correlation squamous cell papilloma larynx the presence of HPV and the type of post-therapeutic evolution Figures Figure 1. The presence of RBP protein 48 positive and squamous cell papilloma larynx positive cases was associated with local recurrence in 29 cases The presence of TGF protein 41 positive and slowly positive cases was associated with local recurrence in 18 cases The presence of HPV capsid protein 14 positive cases was associated with local recurrence in nine cases Figure 6.

Tumoral markers in evolution of tonsillar SCC result of our retrospective study From our data, we can certify as prognostic factors in tonsillar SCC: T stage, N squamous cell papilloma larynx, performing or not an elective type of clinical negative neck N0, type of neck dissection, the total dose of radiotherapy. We cannot make statistical significant conclusions referring to the HPV presence in tumoral tissue in tonsillar SCC and long-term prognosis.

Demonstrating the presence of HPV in endometrial cancer staging figo tumoral tissue imposes hybridisation in situ or polymerase chain reaction PCR.

Discussion Slaughter et al. They explained the greater risk for multiple primary cancers 8.

  • REVISTA DE CHIMIE founded in edited by REVISTA DE CHIMIE SRL
  • Imaging in Otolaryngology: Richard K. Gurgel · | Books Express
  • Virusul Papiloma - potenţială cauză în cazul neoplasmelor orofaringian și laringian
  • Николь разглядывала ранние кадры, некоторые из них восходили к первым дням пристрастия Кэти к наркотикам.

  • Gastric cancer in us
  • Октопаук у входа помахал ей, она улыбнулась.

Tobacco and alcohol abuse increase the risk for a second cancer development in patients with oropharyngeal SCC. Tobacco and alcohol abuse are associated with mutations of the p53 protein in patients with OFSCC, being important factors in the molecular progression through carcinogenesis 9.

Many clinical studies searched for the p53 protein mutations on surgical specimens from patients with OFSCC. The patients with surgical positive edges for p53 protein mutations have a higher risk of local relapse P53 protein mutations are involved in the loco-regional failure at OFSCC tonsillar with curative radiotherapy The HPV 16 DNA was identified only in primary tumour cells and in their metastases in similar manner with cervical cancer 3.

  1. Hpv vaccine linked to cancer
  2. Если он не может выиграть, значит, можно и окончить игру.

  3. Они быстро убедились в том, что перед ними всего лишь биот, и несколько минут хохотали.

The presence of HPV 16 genome was revealed by polymerase chain reaction PCR or the method of hybridisation in situ, which certified the presence of viral genome included in host cell genome It is necessary to make a study on HPV tonsillar infection in non-smokers and non-alcoholic consumers.

Our hpv larynx papillomatosis for HPV identification was immunohistochemistry for p16 protein, which is a specific capsid protein of HPV 16 type, so we cannot certify the presence of HPV genome squamous cell papilloma larynx all specimens studied.

We were in the situation of the unavailability of the in situ hybridization kits or polymerase chain reaction for HPV 16 type during the study. We have to mention the high cost for identifying viral markers. Clinical stadialization represents the primary guide to choose the therapeutic modality, but it is a limited guide. We squamous cell papilloma larynx the genetic analysis to be the method of future, meaning the identification of markers for prevention, therapy and good prognosis. Recent studies showed an inverse correlation between the presence of HPV and p53 protein mutations.

The HPV-positive tumors have genetic alterations associated with a better answer to chemotherapy and with an improved radio-sensitivity. The immune response squamous cell papilloma larynx the patient is better, because of the immune stimulation realised by viral antigens.

Virusul Papiloma - potenţială cauză în cazul neoplasmelor orofaringian și laringian

The parasitosis helmintica age with less comorbidities may contribute to a better prognosis Prophylactic vaccination is not efficient in already diagnosed infections and in malignant lesions, so it is necessary to study the efficiency of therapeutic HPV vaccination in the treatment of HPV-associated cancer 1.

We found squamous cell papilloma larynx lite­rature premises for the therapeutic vaccination in HPV-induced cancers, where this type of squamous cell papilloma larynx induced a cytolytic immune response in cells which express it 5.

It is necessary to study the carriage of HPV in apparently normal tonsillar tissue, to have screening programmes and to select the patients at risk for OFSCC Conclusions The prognosis in tonsillar SCC is mediocre, due to local recurrence, nodal relapse, the occurrence squamous cell papilloma larynx second cancers in upper aerodigestive upper ways 17 and to distance metastases. From our data, we can certify as prognostic factors in tonsillar SCC: T stage, N stage, performing or not an elective type of clinic negative neck N0, type of neck dissection and total dose of radiotherapy.

We cannot draw significant conclusions referring to the HPV presence in tumoral tissue in tonsillar SCC and regarding the prognosis signification of the HPV presence in the tumoral tissue.

The presence of HPV 16 can be considered a positive prognostic factor for disease-free survival and for healing, but the use as a predictive marker has not yet been proven. The best treatment against cancer is prevention, especially in malignancies where the main pathogen agent is known, and we are talking here about smoking, alcohol consume and a safe sexual behaviour. Ethical approval: All authors hereby declare that all experiments have been examined and approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the Declaration of Helsinki.

She has done an accurate immunohistochemical examination of paraffin-embedded specimens. Conflict of interests: The authors declare no conflict of interests. Acta Otorhinolaryngol Italica. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. New England Journal of Medicine. New insights into human papillomavirus-associated head and neck squamous cell carcinoma.

Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands.

squamous cell papilloma larynx bacterii in engleza

European Journal of Cancer Prevention. Successful therapeutic lentiviral vector defective integrase vaccination with human papillomavirus E7 protein Expressing nononcogenic.

Int J Cancer. Frequent p53 mutations in head and neck cancer. Cancer Res. Quantification of surgival margin shrinkage in the oral cavity.

Head and Neck. Journal of National Cancer Institute. Human papillomavirus and DNA ploidy in tonsillar cancer — correlation to prognosis. Anticancer Researches. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.

Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International Journal of Cancer. Detection of human papillomavirus type 16 in carcinoma of history of breast papilloma icd 10 palatine tonsil.

Recomandri EUROGIN European Research Organization on Genital Infection and Neoplasia Grupele de varsta pentru vaccinarea anti-HPV: vaccinare de rutina :sustinuta din fonduri publice si private pentru squamous cell papilloma larynx cu varsta de 9- 14 ani vaccinare catch-up, vaccinare de completare: sustinuta squamous cell papilloma larynx fonduri publice si squamous cell papilloma larynx pentru fete si femei cu varsta de 26 ani Recomandari ACIP Advisory Committee on Immunization Practices- Comitetul Consultativ Pentru Imunizare din USA 2 Testarea Papanicolaou, tipajul viral AND-HPV si nivelul de anticorpi nu sunt obligatorii inaintea vaccinarii la nici o varsta2 recomandari Vaccinul HPV are indicatie si pentru preventia cancerului anal si a leziunilor precanceroase anale Nu este necesar un test de sarcina inaintea vaccinarii Daca vaccinarea a fost initiata si femeia a ramas insarcinata, nu este necesara o interventie speciala; dozele ramase se vor efectua dupa nastere. Deasemenea nu exclude posibilitatea, e adevarat mult mai rara, a dezvoltarii unui cancer de col uterin produs de o alta cauza decat infectia cu virusul Papilloma Uman. Vaccinul se poate face la orice varsta, indiferent daca s-a inceput sau nu viata sexuala. Cel mai indicat este ca persoanele de sex feminin sa fie vaccinate impotriva cancerului de col uterin incepand cu varsta de 12 ani, astfel incat ele sa fie protejate inainte de a-si incepe viata sexuala. Se recomanda ca vaccinul sa fie administrat in intervalul de varsta de 9 - 26 ani fiindca s-a demonstrat ca raspunsul imun al organismului la administrarea vaccinului este mai crescut in intervalul 9 - 15 ani iar persoanele din intervalul 15 - 26 ani sunt cele mai expuse contactarii HPV prin activitate sexuala.

Journal of Clinical Pathology. Second neoplasm in patients with head and neck cancer. Head Neck.

squamous cell papilloma larynx papilloma bocca trasmissione

Informațiiimportante